Association of tissue factor pathway inhibitor with human umbilical vein endothelial cells

Blood

Volumn 90, Issue 9, 1997, Pages 3568-3578

  Hansen, John Bjarne ^a   Olsen, Randi ^b   Webster, Paul ^b  

^a UNIVERSITY OF TROMSØ   (Norway)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; BIOTIN; SERINE PROTEINASE INHIBITOR; TISSUE FACTOR PATHWAY INHIBITOR; TRANSFERRIN RECEPTOR;

ARTICLE; BLOOD CLOTTING; CELL CULTURE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DOSE RESPONSE; ENDOTHELIUM CELL; GOLGI COMPLEX; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; INTERNALIZATION; METABOLISM; PRIORITY JOURNAL; UMBILICAL VEIN;

EID: 0030786195     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.9.3568     Document Type: Article

References (50)

1. Rapaport SI, Rao LVM: The tissue factor pathway: How it has become a "prima ballerina." Thromb Haemost 74:7, 1995
2. Østerud B, Rapaport SI: Activation of factor IX by the reaction product of tissue factor and factor VII: Additional pathway for initiating blood coagulation. Proc Natl Acad Sci USA 74:5260, 1977
3. Rao LVM, Rapaport SI: Studies of a mechanism inhibiting the initiation of the extrinsic pathway of coagulation. Blood 69:645, 1987
4. Broze GJ Jr, Miletich JP: Characterization of the inhibition of tissue factor in serum. Blood 69:150, 1987
5. Girard TJ, Warren LA, Novotny WF, Likert KM, Brown SG, Miletich JP, Broze GJ: Functional significance of the Kunitz-type inhibitor domains of lipoprotein-associated coagulation inhibitor. Nature 338:518, 1989
6. Abumiya T, Enjyoji K, Kokawa T, Kamikubo Y, Kato H: An anti-tissue factor pathway inhibitor (TFPI) monoclonal antibody recognized the third Kunitz domain (K3) of free-form TFPI but not lipoprotein-associated forms in plasma. J Biochem 118:178, 1995
7. Norfang O, Bjørn SE, Valentin S, Nielsen LS, Wildgoose P, Beck TC, Hedner U: The C-terminus of tissue factor pathway inhibitor is essential to its anticoagulant activity. Biochemistry 30:10371, 1991
8. Wesselschmidt R, Likert KM, Girard TJ, Wün TC, Broze GJ Jr: Tissue factor pathway inhibitor: The carboxy-terminus is required for optimal inhibition of factor Xa. Blood 79:2004, 1992
9. Lindhout T, Blezer R, Schoen P, Nordfang O, Reutelingsperger C, Hemker HC: Activation of factor X and its regulation by tissue factor pathway inhibitor in small-diameter capillaries lined with human endothelial cells. Blood 79:2909, 1992
10. Almus FE, Rao LVM, Rapaport SI: Regulation of factor VIIa/ tissue factor functional activity in an umbilical vein model. Arterioscler Thromb 13:105, 1993
11. Sandset PM, Warn-Cramer BJ, Rao LVM, Maki SL, Rapaport SI: Depletion of extrinsic pathway inhibitor (EPI) sensitizes rabbits to disseminated intravascular coagulation induced with tissue factor: Evidence supporting a physiological role for TFPI as a natural anti-coagulant. Proc Natl Acad Sci USA 88:708, 1991
12. Creasey AA, Chang ACK, Feigen L, Wün TC, Taylor FB, Hinshaw LB: Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock. J Clin Invest 91:2850, 1993
13. Lindahl AK, Nordfang O, Wildgoose P, Kelly AB, Harker LA, Hanson SR: Antithrombotic effects of a truncated tissue factor pathway inhibitor in baboons. Thromb Haemost 69:742, 1993 (abstr)
14. Sandset PM, Abildgaard U: Extrinsic pathway inhibitor: The key to feedback control of blood coagulation initiated by tissue thromboplastin. Haemostasis 21:219, 1991
15. Sandset PM, Abildgaard U, Larsen ML: Heparin induces release of extrinsic coagulation pathway inhibitor (EPI). Thromb Res 50:803, 1988
16. Bajaj MS, Kuppuswamy MN, Saito H, Spitzer SG, Bajaj SP: Cultured normal hepatocytes do not synthesize lipoprotein-associated coagulation inhibitor: Evidence that endothelium is the principal site of its synthesis. Proc Natl Acad Sci USA 88:8869, 1990
17. Nemerson Y: Tissue factor and haemostasis. Blood 71:1, 1988
18. Palmier MO, Hall LJ, Reisch CM, Baldwin MK, Wilson AC, Wlin TC: Clearance of recombinant tissue factor pathway inhibitor (TFPI) in rabbits. Thromb Haemost 68:33, 1992
19. Bregengaard C, Norfang O, Østergaard P, Petersen JGL, Meyn G, Diness V, Svendsen O, Hedner U: Pharmacokinetics of full lenth and two-domain tissue factor pathway inhibitor in combination with heparin in rabbits. Thromb Haemost 70:90, 1993
20. Broze GJ Jr: Tissue factor pathway inhibitor. Thromb Haemost 74:90, 1995
21. Warshawsky I, Broze GJ Jr, Schwatz AL: The low density lipoproiein receptor-related protein mediates the cellular degradation of tissue factor pathway inhibitor. Proc Natl Acad Sci USA 91:6664, 1994
22. Warshawsky I, Bu G, Mast A, Saffitz JE, Broze GJ Jr, Schwartz AL: The carboxy-terminus of tissue factor pathway inhibitor is required for interacting with hepatoma cells in vitro and in vivo. J Clin Invest 95:1773, 1995
23. Bangalore N, Drohan WN, Orthner CL: High affinity binding sites for activated protein C and protein C on cultured human umbilical vein endothelial cells. Independent of protein S and distinct from known ligands. Thromb Haemost 72:465, 1994
24. von Asmuth EJ, Smeets EF, Ginsel LA, Onderwater JJ, Leeuwenberg JF, Buurman WA: Evidence for endocytosis of E-selectin in human endothelial cells. Eur J Immunol 22:2519, 1992
25. Conway EM, Boffa MC, Nowakowski B, Steiner-Mosonyi M: An ultrastructural study of thrombomodulin endocytosis: Internalization occurs via clathrin-coated and non-coated pits. J Cell Physiol 151:604, 1992
26. Baker DP, Van-Lenten BJ, Fogelman AM, Edwards PA, Kean C, Berliner JA: LDL, scavanger, and beta-VLDL receptors on aortic endothelial cells. Arteriosclerosis 4:248, 1984
27. Litske Petersen JG, Meyn G, Rasmussen JS, Petersen J, Bjørn SE, Jonassen I, Christiansen L, Norfang O: Characterization of human tissue factor pathway inhibitor variants expressed in saccharomyces cerevisiae. J Biol Chem 268:13344, 1993
28. Erhardsen E, Ezban M, Madsen MT, Diness V, Glazer S, Hedner U, Norfang O: Blocking of tissue factor pathway inhibitor (TFPI) shortens the bleeding time in rabbits with antibody induced haemophilia A. Blood Coagul Fibrinolysis 6:388, 1995
29. Jaffe EA, Nachman RL, Becker CG, Minick CR: Culture of human endothelial cells derived from umbilical cord veins. Identification and immunological criteria. J Clin Invest 52:2245, 1973
30. Czervionke RL, Hoak JC, Fry GL: Effect of aspirin on thrombin-induced adherence of platelets to cultured cells from the vessel wall. J Clin Invest 62:847, 1978
31. Tokuyasu KT: Use of poly(vinylpyrrolidone) and poly(vinyl alcohol) for cryoultramicrotomy. Histochem J 21:163, 1989
32. Liou W, Slot JW: Improved finestructure in immunolabeled cryosections after modifying the sectioning and pick-up conditions. Proceedings of the 13th International Congress on Electron Microscopy, Paris, France, July 17-22, 1994, Vol 3A:253
33. Geuze HJ, Slot JW, van der Ley P, Scheffer RCT: Use of colloical gold particles in double labelling immunoelectron microscopy of ullralhin tissue sections. J Cell Biol 89:653, 1981
34. Slot JW, Geuze HJ, Gigengack S, Lienhard GE, James DE: Immuno-localization of the insulin regulatable glucose transporter in brown adipose tissue of the rat. J Cell Biol 113:123, 1991
35. Griffiths G, Brands R, Burke B, Louvard D, Warren G: Viral membrane proteins aquire galuctosyl in trans Golgi cisternae during intracellular transport. J Cell Biol 95:781, 1982
36. Anderson RGW, Falck JR, Goldstein JL, Brown MS: Visualization of acidic organeiles in intact cells by electron microscopy. Proc Natl Acad Sci USA 81:4838, 1984
37. Mayhew TM, Gundersen HJ: If you assume, you can make an ass out of u and me: A decade of the disector for stereological counting of particles in 3D space. J Anat 188:1, 1996
38. Lucocq J: Quantitation of gold labelling and antigens in immunolabelled ultrathin sections. J Anat 184:1, 1994
39. Markwell MAK: A new solid-state reagent to iodinate proteins: Conditions for the efficient labelling of antiserum. Anal Biochem 125:427, 1982
40. Hansen JB, Huseby KR, Huseby NE, Sandset PM, Hansen TA, Nordøy A: Effect of cholesterol lowering on intravascular pools of TFPI and its anticoagulant potential in type II hyperlipoproteinemia. Arterioscler Thromb Vase Biol 15:879, 1995
41. Warn-Cramer BJ, Almus FE, Rapaport SI: Studies of the factor Xa-dependent inhibitor of factor VIIa/tissue factor (extrinsic pathway inhibitor) from cell supernates of cultured human umbilical vein endothelial cells. Thromb Haemost 61:101, 1989
42. Ameri A, Kuppuswamy MN, Basu S, Bajaj SP: Expression pf tissue factor pathway inhibitor by cultured endothelial cells in response to inflammatory mediators. Blood 79:3219, 1992
43. Rapaport SI: The extrinsic pathway inhibitor: A regulator of tissue factor dependent blood coagulation. Thromb Haemost 66:6, 1991
44. Grabowaki EF, Zuckerman DB, Nmerson Y: The functional ..expression of tissue factor by fibroblasts and endothelial cells under flow conditions. Blood 81:3265, 1993
45. Valentin S, Larnkjæ A, Østergaard P, Nielsen JI, Norfang O: Characterization of the binding between tissue factor pathway inhibitor and glycosaminoglycans. Thromb Res 75:173, 1994
46. Kornfeld S, Mellman I: The biogenesis of lysosomes. Annu Rev Cell Biol 5:483, 1989
47. Griffiths G, Hoflack B, Simons K, Mellman I, Kornfeld S: The mannose 6-phosphate receptor and the biogenesis of lysosomes. Cell 52:329, 1988
48. Klausner RD, Ashwell G, van Renswoude J, Harford JB, Bridges KR: Binding of apotransferrin to K562 cells: Explanation of the transferrin cycle. Proc Natl Acad Sci USA 80:2263, 1983
49. Sevinsky JR, Rao LVM, Ruf W: Ligand-induced protease receptor translocation into caveolae: A mechanism for regulating cell surface proteolysis of the tissue factor-dependent coagulation pathway. J Cell Biol 133:293, 1996
50. Ho G, Toomey JR, Broze GJ Jr, Schwartz AL: Receptor-mediated endocytosis of coagulation factor Xa requires cell surface-bound tissue factor pathway inhibitor. J Biol Chem 271:9497, 1996